–
Closing
–
1D
–
YTD
Market cap
-
52 week high
-
52 week low
-
Volume
-
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
-
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
2
P/E
-
Operating Margin
-
Beta
-
Revenue Growth
-
52 week high
-
52 week low
-
Div. Yield
-
EPS Growth
-
Company Profile
Bone Therapeutics SA is a Belgium-based company developing cell therapy products. The Company develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. It is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation.The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.
